checkAd

     198  0 Kommentare Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update - Seite 3

    Contact:

    Investors 
    Maren Killackey
    Generation Bio
    mkillackey@generationbio.com
    541-646-2420

    Media 
    Alicia Webb
    Generation Bio
    awebb@generationbio.com
    847-254-4275

    Lesen Sie auch

    Stephanie Simon 
    Ten Bridge Communications
    stephanie@tenbridgecommunications.com
    617-581-9333



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update - Seite 3 Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing Lease agreement signed to build an in-house RES manufacturing facility providing cGMP …